Does Dr. EMILIE ADEKANBI have financial conflicts of interest?

Dr. EMILIE ADEKANBI (FNP-C) has received a total of $486 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $486 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EMILIE ADEKANBI?

According to CMS Open Payments data, Dr. EMILIE ADEKANBI received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($162), ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($126), and E.R. SQUIBB & SONS, L.L.C ($77).

Does Dr. EMILIE ADEKANBI receive research grants or speaking fees?

Dr. EMILIE ADEKANBI has received $486 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. EMILIE ADEKANBI

FNP-CReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: LAKE CHARLES, LA 70605

NPI Number: 1093462376

LIFETIME INDUSTRY VALUE

$486

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADEKANBI is a verified Nurse Practitioner, Family practitioner based in LAKE CHARLES, LA.

Between 2021 and 2024, Dr. ADEKANBI had an overall industry promotional and research financial footprint of $486 as recorded in the federal CMS Open Payments database.

$486 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADEKANBI's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $162 (representing 33.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$162

33.4%

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 2

$126

26%

E.R. SQUIBB & SONS, L.L.C

Rank 3

$77

15.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.